Characteristic | HIV+ (n = 171) | HIV-(n = 97) | P |
---|---|---|---|
Median age, years (IQR) | 54.5 (50.4, 59.5) | 55.5 (51.6, 59.9) | 0.33 |
Male sex, n (%) | 170 (99%) | 97 (100%) | 0.45 |
Race/ethnicity, n (%) | Â | Â | 0.40 |
 White | 26 (15%) | 10 (10%) |  |
 Black/African American | 131 (77%) | 82 (84%) |  |
 Hispanic | 11 (6%) | 3 (3%) |  |
 Other | 3 (2%) | 2 (2%) |  |
Body mass index, n (%) | Â | Â | 0.007 |
 < 18.5 kg/m2 | 4 (2%) | 0 |  |
 18.5–24.9 kg/m2 | 70 (41%) | 30 (31%) |  |
 25.0–29.9 kg/m2 | 68 (40%) | 34 (35%) |  |
 ≥ 30.0 kg/m2 | 29 (14%) | 33 (34%) |  |
Median SAT area, cm2 (IQR) | 183.4 (107.4, 270.5) | 251.2 (184.2, 348.0) | < 0.001 |
Median VAT area, cm2 (IQR) | 95.3 (48.7, 142.7) | 106.4 (58.4, 148.5) | 0.39 |
Diabetes mellitusa, n (%) | 33 (19%) | 19 (20%) | 0.95 |
Hypertensionb, n (%) | 140 (82%) | 80 (83%) | 0.77 |
Alcohol consumptionc, n (%) | Â | Â | 0.28 |
 Not current | 59 (34%) | 29 (30%) |  |
 Non-hazardous | 33 (19%) | 12 (12%) |  |
 Hazardous/at risk | 13 (8%) | 9 (9%) |  |
 Dependence/abuse | 66 (39%) | 47 (48%) |  |
Current ART use, n (%)d | 156 (91%) | – | – |
Median years on ART (IQR) | 6.3 (3.8–9.6) | – | – |
Median HIV RNA, copies/mm3 (IQR) | 48 (40, 72) | – | – |
HIV RNA < 75 copies/mm3, n (%) | 141 (82%) | – | – |
Median nadir CD4 count, cells/mm3 (IQR) | 196.5 (79, 320) | – | – |
Median current CD4 cell count, cells/mm3 (IQR) | 462 (300, 673) | – | – |
Current CD4 cell count category, n (%) |  | – | – |
 < 200 cells/mm3 | 19 (11%) |  |  |
 200–350 cells/mm3 | 39 (23%) |  |  |
 350–500 cells/mm3 | 35 (20%) |  |  |
 > 500 cells/mm3 | 77 (45%) |  |  |
 Missing | 1 (1%) |  |  |
HCV infection, n (%)e | 93 (54%) | 47 (48%) | 0.35 |
Median ALT, U/L (IQR) | 29 (22, 42) | 29 (19, 44) | 0.85 |
Median AST, U/L (IQR) | 31.6 (24, 45) | 28 (22.5, 43.5) | 0.36 |
Median total cholesterol, mg/dL (IQR) | 173 (151, 199) | 176 (153, 200) | 0.56 |
Median triglycerides, mg/dL (IQR) | 120 (90, 198) | 96 (73.5, 149.5) | 0.002 |
Median high-density lipoprotein, mg/dL (IQR) | 41 (33, 53) | 44.5 (35.5, 57.5) | 0.08 |
FIB-4, n (%) |  |  | < 0.001 |
 < 1.45 | 75 (44%) | 51 (53%) |  |
 1.45–3.25 | 72 (42%) | 28 (29%) |  |
 > 3.25 | 21 (12%) | 5 (5%) |  |
 Missing | 3 (2%) | 13 (13%) |  |